发明名称 |
METHODS FOR ENHANCING IMMUNOSUPPRESSIVE THERAPY BY MULTIPLE ADMINISTRATION OF ALPHA BETA TCR-BINDING POLYPEPTIDE |
摘要 |
The present disclosure is related to improved methods for use of a humanized binding polypeptide specific for the alpha beta T cell receptor (αβ-TCR). In particular, this disclosure relates to improved methods of use of a humanized anti-αβ-TCR antibody, which is derived from the murine monoclonal antibody BMA031, in immunosuppressive therapy. Novel methods using humanized monoclonal antibodies and/or humanized monoclonal antibody fragments (e.g., anti-αβTCR antibodies and/or fragments thereof) are also provided. Novel methods using repetitive administration of humanized monoclonal antibodies and/or humanized monoclonal antibody fragments (e.g., anti-αβTCR antibodies and/or fragments thereof) to reduce αβ T cells in the subject relative to γδ cells in the subject are provided. |
申请公布号 |
US2016244523(A1) |
申请公布日期 |
2016.08.25 |
申请号 |
US201415029770 |
申请日期 |
2014.10.30 |
申请人 |
GENZYME CORPORATION ;CHILDREN'S UNIVERSITY HOSPITAL TÜBINGEN |
发明人 |
Blank Gregor;Handgretinger Rupert;Schilbach Karin;Lacorcia Gina;Snell Daniel;Menrad Andreas |
分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of preferentially reducing αβ T cells relative to γδ T cells in a subject, comprising administering to the subject a humanized anti-αβTCR binding polypeptide in two or more doses. |
地址 |
Cambridge MA US |